Gender differences in efficacy and sexual function in long-term trazodone treatment (preliminary results)

References

• Hensley PP, Nurnberg HG. SSRI Sexual dysfunction: A female perspective. J Sex Marital Ther 2002; 28: 143–53
   PubMed Web of Science ®Google Scholar
• Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 2000; 157: 1445–52
   PubMed Web of Science ®Google Scholar
• Baca E, Garcia-Garcia M, Porras-Chavarino A. Gender differences in treatment responses to sertraline versus imipramine in patients with nonmelancholic depressive disorders. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 57–65
   PubMed Web of Science ®Google Scholar
• Parker G, Parker K, Austin MP, Mitchell P, Brotchie H. Gender differences in response to differing antidepressant drug classes: Two negative studies. Psychol Med 2003; 33: 1473–7
   PubMed Web of Science ®Google Scholar
• Hildebrandt MG, Steyerberg EW, Stage KB, Passchier J, Kragh-Soerensen P. Are gender differences important for the clinical effects of antidepressants?. Am J Psychiatry 2003; 160: 1643–50
   PubMed Web of Science ®Google Scholar
• Scheibe S, Preuschhof C, Cristi C, Bagby RM. Are there gender differences in major depression and its response to antidepressants?. J Affect Disord 2003; 75: 223–35
   PubMed Web of Science ®Google Scholar
• Hawton K, Gath D, Day A. Sexual function in a community sample of middle-age women with partners: Effects of age, marital, socioeconomic, psychiatric, gynecological, and menopausal factors. Arch Sexual Behav 1994; 23: 375–95
   PubMed Web of Science ®Google Scholar
• Shen WW, Hsu JH. Female sexual side effects associated with selective serotonin reuptake inhibitors: A descriptive clinical study of 33 patients. Int J Psychiatry Med 1995; 25: 239–48
   PubMed Web of Science ®Google Scholar
• Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS. Nefazodone versus sertraline in outpatients with major depression: Focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry 1996; 57(Suppl 2)53–62
   PubMed Web of Science ®Google Scholar
• Piazza LA, Markowitz JC, Kocsis JH, Leon AC, Portera L, Miller NL, Adler D. Sexual functioning in chronically depressed patients treated with SSRI antidepressants: A pilot study. Am J Psychiatry 1997; 154: 1757–9
   PubMed Web of Science ®Google Scholar
• Segraves RT, Balon R. Sexual pharmacology: Fast facts. Norton & Company Inc, New York 2003
   Google Scholar
• Lingjaerde O, Ahlfors VG, Dencker SJ, Elgen K. The UKU side effects rating scale for psychotropic drugs and a cross sectional study of side effects in antipsychotic patients. Acta Psychiatr Scand 1987; Suppl:1–100.
   Google Scholar
• McGahuey CA, Delgado PL, Gelenberg AJ. Assessment of sexual dysfunction using the Arizona sexual experiences scale (ASEX) and implications for the treatment of depression. Psychiatr Ann 1999; 29: 39–45
   Web of Science ®Google Scholar
• Clayton AH, McGarvey EL, Clavet GJ, Piazza L. Comparison of sexual functioning in clinical and nonclinical populations using the Changes in Sexual Functioning questionnaire (CSFQ). Psychophamacol Bull 1997; 33: 731–45
   PubMed Web of Science ®Google Scholar
• Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, Khan ZM. Antidepressant-induced sexual dysfunction. Ann Pharmacother 2002; 36: 1577–89
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline and venlafaxine. J Clin Psychiatry 2000; 61: 276–81
   PubMed Web of Science ®Google Scholar
• Altmann M, Kulogla M, Tencan E, Buyukbayenn S. Switching to tianeptine in patients with antidepressant-induced sexual dysfunction. Hum Psychopharmacol 2003; 18: s277–80
   Google Scholar
• Clayton AH, Zajecka J, Ferguson JM, Filipiak-Reisner JK, Brown MT, Schwartz GE. Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder. Int Clin Psychopharmacol 2003; 18: 151–6
   PubMed Web of Science ®Google Scholar
• Silvestrini B, Cioli V, Burberi S, Cataned B. Pharmacological properties of AF1161, a new psychotropic agent. Int J Neuropharmacol 1968; 7: 587–99
   PubMedGoogle Scholar
• Burke MJ, Preskorn SH. Short-term treatment of mood disorders with standard antidepressants. Psychopharmacology: The fourth generation of progress, FE Bloom, DJ Kupfer. Raven Press, New York 1995; 1053–65
   Google Scholar
• World Health Organization. International classification of mental and behavioural disorders. Geneva: WHO; 1992.
   Google Scholar
• Guy W. ECDU Assessment Manual for Psychopharmacology. US Dept Health, Education and Welfare publication (ADM). 76–338. Rockville, MD: National Institute of Mental Health; 1976. p 218–22.
   Google Scholar
• Weissman NM, Clerman GL. Sex differences and the epidemiology of depression. Arch Gen Psychiatry 1977; 34: 98–111
   PubMed Web of Science ®Google Scholar
• Kornstein SG. Gender differences in depression: Implications for treatment. J Clin Psychiatry 1997; 58(Suppl 15)S12–8
   PubMed Web of Science ®Google Scholar
• Hamilton JA, Grant M, Jensvold MF. Sex and treatment of depression: When does it matter?. Psychopharmacology and women, MF Jensvold, U Halbreich, JA Hamilton. American Psychiatric Press, Washington, DC 1996; 241–57
   Google Scholar
• Frackiewicz EJ, Sramek JJ, Cutler NR. Gender differences in depression and antidepressant pharmacokinetics and adverse events. Ann Pharmacother 1996; 34: 80–8
   Google Scholar
• Williams JB, Spitzer RL. The issue of sex biasis in DSM III. A critique of ‘A woman′s view of DSM III’ by Marcie Kaplan. Am Psychol 1983; 38: 793–8
   PubMed Web of Science ®Google Scholar
• Stahl SM. Essential psychopharmacology. 2nd ed. Cambridge University Press, Cambridge 2000
   Google Scholar
• Wohlfarth T, Storosum JG, Elferink AJ, van Zwieten BJ, Fouwels A, van den Brink W. Response to tricyclic antidepressants: Independent of gender?. Am J Psychiatry 2000; 161: 370–2
   Google Scholar
• Weiss P, Zvěřina J. Sexuální chování obyvatel ČR. Portál, Prague 2001
   Google Scholar
• Meston CM, Gorzalka BB. Psychoactive drugs and human sexual behaviour: The role of serotonergic activity. J Psychoactive Drugs 1992; 24: 1–40
   PubMed Web of Science ®Google Scholar
• Perry PJ, Alexander B, Liskow BI, editors. Psychotropic drug handbook. Washington, DC: American Psychiatric Press; 1997.
   Google Scholar
• Fink HA, MacDonald R, Rulks IR, Wiet TJ. Trazodone for erectile dysfunction: A systemetic review and meta-analysis. Br J Urol Int 2003; 92: 441–6
   Google Scholar
• Česková E, Žourková A, Skotáková S, Kašpárek T. The pitfalls of antidepressant treatment (gender differences). Psychiatrie (Prague) 2004; 8(Suppl 4)16–7
   Google Scholar